Trump Administration Faces Pressure to Address Chinese AI Model Distillation
Policy analysts argue that existing export controls do not cover the practice of extracting capabilities from American AI systems, leaving a regulatory gap that the administration has not yet...
The Trump administration's September 2026 diplomatic and technology summits have drawn attention to a specific AI practice, known as distillation, through which foreign developers can replicate the capabilities of advanced American AI models without directly copying their code, according to a Washington Examiner analysis published October 9, 2026.
President Trump held two separate summits in September 2026. The first was a bilateral meeting with Chinese President Xi Jinping, described by the White House as focused in part on risks posed by powerful AI systems. The second, referred to publicly as a "superintelligence summit," convened technology executives and produced a set of voluntary commitments on AI safety. Neither the meeting readout nor the summit commitments, as published, addressed model distillation by name. The White House has not publicly released the full text of the AI safety commitments as of the date of this article.
Model distillation is a technical process in which a smaller AI model is trained to replicate the outputs of a larger, more capable model. Because distillation works from outputs rather than from model weights or source code, it is not directly covered by the Commerce Department's existing export controls on advanced semiconductors, which were updated in October 2023 and again in January 2025 under Bureau of Industry and Security rules. Whether the practice constitutes a violation of any current regulation depends on specific facts that would be established through enforcement proceedings, not editorial analysis.
The administration's primary legislative tool for AI governance remains the executive order framework. President Biden issued Executive Order 14110 on AI safety in October 2023. President Trump revoked that order in January 2025 and replaced it with Executive Order 14179, which emphasized American AI dominance and directed agencies to revise regulations seen as barriers to AI development. Neither order contains explicit language addressing model distillation as a category of technology transfer.
Congress has not passed standalone AI regulation as of October 2026. The Senate Commerce Committee held hearings on AI policy in 2025, and several bills have been introduced, including the Artificial Intelligence Research, Innovation, and Accountability Act, but none has advanced to a floor vote in either chamber. The congressional record does not reflect any markup of AI-specific legislation in the 119th Congress as of this writing.
The Federal Trade Commission and the Department of Justice have both opened inquiries into competition in the AI sector, according to public statements from those agencies issued in 2024 and 2025. Neither agency has publicly announced an investigation specifically targeting model distillation practices by Chinese firms.
The Commerce Department's Bureau of Industry and Security has authority under the Export Administration Regulations to designate technologies as export-controlled. Whether BIS is reviewing model distillation for potential designation is not known. A designation proceeding would be reflected in the Federal Register when initiated. No such notice appears in the Federal Register as of October 9, 2026.
The Trump-Xi summit communique, as released, stated that both sides agreed to continue government-to-government dialogue on AI risk. It did not specify enforcement mechanisms, timelines, or the scope of AI practices under discussion. The full diplomatic record of the meeting, including any side agreements or technical annexes, has not been made public.
The policy question of whether distillation should be regulated sits at the intersection of trade law, export control authority, and intellectual property law. Legal scholars cited in the Washington Examiner piece argue that current statutes do not provide a clear enforcement pathway. What statute, if any, the administration would invoke to restrict the practice, and whether it would require new legislation, remains publicly unresolved.
What is still unknown includes whether the administration has directed BIS to review distillation for export control designation, whether the AI safety commitments from the September summit contain nonpublic annexes addressing the practice, and whether any Congressional committee has received a classified briefing on the subject. A Freedom of Information Act request to BIS or a congressional oversight inquiry to the Commerce Department would be the public records mechanisms most likely to answer those questions.